Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
2015 · Nature reviews. Cancer · 1,366 citations
https://doi.org/10.1038/nrc4019
E
Ernst Lengyel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
571
Papers
29.5K
Citations
72
h-index
159
i10-index
Ernst Lengyel is an academic researcher from Gynecologic Oncology Group. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & MicroRNA in disease regulation. The author has an h-index of 72, co-authored 486 publications.
ORCID: 0000-0001-8624-1507Papers by this author
worksDeep Visual Proteomics defines single-cell identity and heterogeneity
2022 · Nature Biotechnology · 476 citations
https://doi.org/10.1038/s41587-022-01302-5
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
2015 · Nature Communications · 176 citations
https://doi.org/10.1038/ncomms7220
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis
2010 · Neoplasia · 75 citations
https://doi.org/10.1593/neo.09948
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
2019 · Molecular Cancer Research · 73 citations
https://doi.org/10.1158/1541-7786.mcr-18-0409
Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface
2007 · Journal of Biological Chemistry · 71 citations
https://doi.org/10.1074/jbc.m704855200
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat